Morgan Stanley Dexcom Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Dexcom Inc stock. As of the latest transaction made, Morgan Stanley holds 5,255,806 shares of DXCM stock, worth $418 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,255,806

Previous 5,630,946 6.66%

Holding current value

$418 Million

Previous $638 Million 44.83%

% of portfolio

0.03%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $24 Million - $43.5 Million	-375,140 Reduced 6.66%	5,255,806 $352 Million
Q2 2024 Oct 17, 2024	BUY	$110.31 - $140.45 $66 Million - $84 Million	598,177 Added 11.89%	5,630,946 $638 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $66 Million - $84 Million	598,177 Added 11.89%	5,630,946 $638 Million
Q1 2024 Oct 17, 2024	SELL	$114.22 - $140.1 $68.3 Million - $83.8 Million	-598,177 Reduced 10.62%	5,032,769 $698 Million
Q1 2024 Aug 16, 2024	SELL	$114.22 - $140.1 $7.88 Million - $9.67 Million	-69,031 Reduced 1.35%	5,032,769 $698 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $7.88 Million - $9.67 Million	-69,031 Reduced 1.35%	5,032,769 $698 Million
Q4 2023 Aug 16, 2024	SELL	$75.49 - $124.16 $39.9 Million - $65.7 Million	-529,146 Reduced 9.4%	5,101,800 $633 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $51.2 Million - $84.2 Million	677,865 Added 15.32%	5,101,800 $633 Million
Q3 2023 Nov 15, 2023	BUY	$86.06 - $137.93 $21.1 Million - $33.8 Million	245,364 Added 5.87%	4,423,935 $413 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $551,327 - $642,063	4,902 Added 0.12%	4,178,571 $537 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $15.3 Million - $18 Million	-146,841 Reduced 3.4%	4,173,669 $485 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $3.41 Million - $4.92 Million	-40,148 Reduced 0.92%	4,320,510 $489 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $2.23 Million - $2.75 Million	-29,191 Reduced 0.66%	4,360,658 $351 Million
Q2 2022 Oct 27, 2022	BUY	$67.99 - $132.89 $251 Million - $490 Million	3,690,913 Added 528.08%	4,389,849 $327 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $251 Million - $490 Million	3,690,913 Added 528.08%	4,389,849 $327 Million
Q1 2022 Oct 27, 2022	SELL	$94.08 - $130.2 $347 Million - $481 Million	-3,690,913 Reduced 84.08%	698,936 $358 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $14.6 Million - $20.2 Million	-155,495 Reduced 18.2%	698,936 $358 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $50.8 Million - $63.7 Million	-391,089 Reduced 31.4%	854,431 $459 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $133 Million - $178 Million	1,245,520 New	1,245,520 $681 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.7B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account